[Management of iron overload during pregnancy and childbirth in a patient with ferroportin disease]

Rinsho Ketsueki. 2023;64(11):1410-1414. doi: 10.11406/rinketsu.64.1410.
[Article in Japanese]

Abstract

An asymptomatic woman in her early 40s with a history of hyperferritinemia (5,412 ng/ml) was referred to our hospital after repeated phlebotomy for hemosiderosis. She had unexplained hyperferritinemia, low-normal transferrin saturation, and high hepcidin levels, in the absence of iron overload-induced organ injury. She was diagnosed with ferroportin disease based on detection of the SLC40A1 variant SLC40A1 c.485_487del (p.Val162del) on genetic analysis. Her ferritin levels remained stable during pregnancy, and postpartum anemia was successfully treated with 2-week oral iron therapy. Ferroportin disease is characterized by impaired iron export and preferential iron trapping in tissue macrophages. To reduce risk of anemia, a non-aggressive phlebotomy regimen is recommended in patients with ferroportin disease, which shows a milder clinical course compared with other classical hemochromatosis subtypes.

Keywords: Ferroportin disease; SLC40A1; Serum ferritin; Transferrin saturation.

Publication types

  • English Abstract

MeSH terms

  • Anemia*
  • Female
  • Hemochromatosis* / diagnosis
  • Hemochromatosis* / genetics
  • Hemochromatosis* / therapy
  • Hepcidins
  • Humans
  • Hyperferritinemia*
  • Iron
  • Iron Overload* / etiology
  • Pregnancy

Substances

  • metal transporting protein 1
  • Iron
  • Hepcidins

Supplementary concepts

  • Hemochromatosis, type 4